$205 Million is the total value of Kalos Management, Inc.'s 194 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEA | NUVEEN AMT FREE QUALITY | $379,000 | +0.3% | 30,802 | 0.0% | 0.18% | -8.9% | |
| CTSO | CYTOSORBENTS CORPORATION | $120,000 | -31.8% | 14,700 | 0.0% | 0.06% | -38.3% | |
| FOLD | AMICUS THERAPEUTICS INC | $117,000 | -7.1% | 10,750 | 0.0% | 0.06% | -16.2% | |
| HINES GLOBAL REIT INC | $112,000 | 0.0% | 12,422 | 0.0% | 0.06% | -8.3% | ||
| PSLV | SPROTT PHYSICAL SILVER TR TR UNIT | $70,000 | +7.7% | 12,367 | 0.0% | 0.03% | -2.9% | |
| MCC | MEDLEY CAPITAL CORPORATION | $35,000 | -27.1% | 13,500 | 0.0% | 0.02% | -34.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 30 | Q2 2023 | 2.9% |
| APPLE INC COM | 29 | Q2 2023 | 2.7% |
| ISHARES TRUST | 29 | Q2 2023 | 1.3% |
| ISHARES TR | 28 | Q2 2023 | 5.9% |
| VANGUARD S&P 500 ETF IV | 28 | Q2 2023 | 4.2% |
| ISHARES US HEALTHCARE ETF IV | 28 | Q2 2023 | 4.7% |
| VANGUARD TAX-MANAGED FDS | 28 | Q1 2023 | 1.3% |
| SPDR S&P EMERGING MRKT SML CP ETF | 28 | Q2 2023 | 1.2% |
| ISHARES US TECHNOLOGY ETF | 28 | Q2 2023 | 1.8% |
| SPDR S&P 500 VALUE ETF IV | 28 | Q2 2023 | 0.7% |
View Kalos Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-10-16 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-27 |
| 13F-HR | 2022-11-21 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-06-21 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-11 |
View Kalos Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.